RxDoctor Payments DataLook up a doctor →

Miguel Mujica Baella, MD

Hospitalist · Miami, FLNPI 1962611673

Payments from drug & device makers

$1,825,403in general payments, 2019–2025

Across 314 payments — averaging $5813.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Chiesi USA, Inc.$973K
  • Eli Lilly$433K
  • Teva Pharmaceuticals USA, Inc.$275K
  • Merck$99K
  • Astrazeneca UK Limited$26K
  • Genentech, Inc.$19K
  • plus $459 from 3 others
$5,710in research payments, 2019–2025

Across 2 payments — averaging $2855.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$6K

General payments by program year

22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,825,403 in reported general payments places this provider in the 95th percentile of 1,570 hospitalist providers in Florida.

See all hospitalist providers in Florida

Medicare billing

Part B allowed, 2024
$140,898
Medicare patients
220
Services billed
1,316

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hospitalist in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →